๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The treatment of hypertension in obese patients

โœ Scribed by Marion R. Wofford; Grant Smith; Deborah S. Minor

Publisher
Springer
Year
2008
Tongue
English
Weight
176 KB
Volume
10
Category
Article
ISSN
1522-6417

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Adverse Events in the Treatment of Hyper
Adverse Events in the Treatment of Hypertensive Patients
โœ Gaetana Palumbo; Lorenza Salani; Paola Longhini; Carmela La Guidara; Valter Scar ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 573 KB

We evaluated frequency and type of adverse events (AE) and measures adopted in outpatients attending a hospital hypertension unit in a two-part study: ( I ) a retrospective review of the charts of the 412 patients seen in 1991 with at least one follow-up visit and (2) a prospective study of the 491

Effect of dexfenfluramine treatment on b
Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients
โœ J. Kolanowski; L. T. Younis; R. Vanbutsele; J. -M. Detry ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 839 KB

The effect of dexfenfluramine (dF) on body weight, blood pressure and noradrenergic activity were studied in 30 obese hypertensive patients randomly divided into two groups and treated for 3 months either with dF (30 mg daily; 16 subjects) or placebo (Pl; 14 subjects). 11 patients from the dF group